MDIN MedGen Inc (CE)

Med Gen Inc. (OTCBB:MDIN), manufacturers of nationally branded OTC healthier life products and specialty financial services, reports the signing of a two-year exclusivity agreement with Dr. Barbara Levine, R.D.,Ph.D, Associate Clinical Professor at the Weil Medical College of Cornell University. Besides her present position at Weil-Cornell, Dr. Levine has held various positions at The Rockefeller University, Hospital For Special Surgery, DHA Information Center, Albert Einstein College Of Medicine and others. �Having Dr. Levine on our staff and as our Spokesperson puts Med Gen�s Good Nights Sleep� in an enviable position,� said Paul Kravitz, Chief Executive. Twelve years ago the company launched Snorenz�, a unique snoring relief spray, during the first 12 months the company�s distributor booked sales of approximately $25 million. Management believes that Good Nights Sleep� sleep strips has a market 10 times the size. Putting it together and making it work is the focus of the company and the company has hired TransMedia Group.com and Dr. Levine, to make sure the story gets out to the 1.5 billion potential users. For those who want to learn more about Med Gen and the Sleep Strips go to www.4goodnightsleep.com and www.medgen.com. About Med Gen Inc. Med Gen Inc., in business since 1996, manufactures and markets specialty products using its proprietary delivery system Spray�s the Way (�STW�). It is best known for producing the world�s first patented liquid spray snoring relief formula, Snorenz�. Since its existence, Med Gen has continued to develop its STW technology, introducing Good Nights Sleep�, the UnDiet� system and GOOD NIGHTS SLEEP� Sleep Strips into its family of brands. FabULust�, the company�s newest product, a female sexual stimulant, has been launched in test markets throughout the country. While STW technology is mainly used, the company also produces other products that deal with common health issues using other delivery systems. The company markets its products to distributors, direct sales via the company web site and direct to consumer television, radio and print advertising. The company also distributes its brands internationally under various private labels or existing names. The Company also offers specialty financial and investment services through its Financial Services division, to small emerging public companies. Med Gen Inc. is a fully reporting company whose stock trades on the OTCBB under the symbol �MDIN�. For information contact Investor Relations 561-750-1100 or www.medgen.com This Press Release contains or incorporates by reference �forward looking� statements including certain information with respect to plans and strategies of Med Gen Inc. For this purpose, any statements contained herein or incorporated herein by references that are not statements of historical fact may be deemed forward looking statements. Without limiting the foregoing, the words �believes�, �suggests�, �anticipates�, �plans�, �expects�, and similar expressions are intended to identify forward looking statements. There are a number of events or actual results of Med Gen operations that could differ materially from those indicated by such forward looking statements.